Abstract CT076: AFNT-211: A Phase1 Study of Autologous CD4+ and CD8+ T Cells Engineered to Express a High Avidity HLA-A*11:01-restricted, KRAS G12V-specific, Transgenic TCR; CD8α/β Coreceptor; and a FAS41BB Switch Receptor in Patients with Advanced/metastatic Solid Tumors
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined